These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 751902)

  • 61. Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies.
    Coccia PF; Kersey JH; Gajil-Peczalska KJ; Krivit W; Nesbit ME
    Am J Hematol; 1976; 1(4):405-17. PubMed ID: 795293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines.
    Wiels J; Holmes EH; Cochran N; Tursz T; Hakomori S
    J Biol Chem; 1984 Dec; 259(23):14783-7. PubMed ID: 6438103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Acute leukemia with Burkitt's lymphoma cells in two Japanese children--clinical manifestations and cell surface markers--(author's transl)].
    Kusakari A; Nakazawa S; Takane K; Yamada K
    Rinsho Ketsueki; 1981 Dec; 22(12):1962-70. PubMed ID: 6980299
    [No Abstract]   [Full Text] [Related]  

  • 64. Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment.
    Bazerbashi MB; Chanarin I; Denman AM
    Postgrad Med J; 1980 Feb; 56(652):92-101. PubMed ID: 7393803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Actin co-caps with concanavalin A receptors.
    Toh BH; Hard CC
    Nature; 1977 Oct; 269(5630):695-7. PubMed ID: 593328
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of membrane proteins of Burkitt's lymphoma and EBV-transformed B lymphoblast cell lines and of Con A-activated T lymphocytes and T lymphoblast cell lines.
    Spiro RC; DeMartino JL; Boto W; Lazarus H; Humphreys RE
    Leuk Res; 1979; 3(5):315-27. PubMed ID: 230395
    [No Abstract]   [Full Text] [Related]  

  • 67. High terminal deoxynucleotidyl transferase activity in pediatric patients with acute lymphocytic and acute myelocytic leukemias.
    Sahai Srivastava BI; Khan SA; Minowada J; Freeman A
    Int J Cancer; 1978 Jul; 22(1):4-9. PubMed ID: 277433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human spontaneous killer cells selective for tumour-derived target cells.
    Jondal M; Spine C; Targan S
    Nature; 1978 Mar; 272(5648):62-4. PubMed ID: 305005
    [No Abstract]   [Full Text] [Related]  

  • 69. Changes in the surface membrane of lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
    Mintz U; Sachs L
    Int J Cancer; 1975 Feb; 15(2):253-9. PubMed ID: 1126758
    [No Abstract]   [Full Text] [Related]  

  • 70. Mobility of Concanavalin A receptors on the surface membrane of lymphocytes from normal persons and patients with chronic lymphocytic leukemia.
    Ben-Bassat H; Goldblum N; Manny N; Sachs L
    Int J Cancer; 1974 Sep; 14(3):367-71. PubMed ID: 4459272
    [No Abstract]   [Full Text] [Related]  

  • 71. Human lymphoid cell lines and glucocorticoids: I. Characterization and cytolethal responses of lymphoblastoid, leukaemia and lymphoma lines.
    Burrow HM; Bird CC; Warren JV; Steel CM; Barrett ID; Panesar NS
    Diagn Histopathol; 1981; 4(2):175-88. PubMed ID: 6973456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blastogenic response of lymphocytes derived from patients with hematopoietic malignancies to antigens of a type C retrovirus isolated from a Burkitt's lymphoma cell line.
    Schwarzbard Z; Gotlieb-Stematsky T; Vonsover A; Djaldetti M; Hallak A; Yaniv A
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1411-20. PubMed ID: 6315444
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis.
    Budzko DB; Lachmann PJ; McConnell I
    Cell Immunol; 1976 Mar; 22(1):98-109. PubMed ID: 1277295
    [No Abstract]   [Full Text] [Related]  

  • 74. Surface morphology and membrane phenotype of cultured human leukemia-lymphoma cells. A scanning electron microscopic study of 36 cell lines.
    Polliack A; Gamliel H; Ben Bassat H; Gurfel D; Leizerowitz R; Minowada J
    Cancer; 1983 Jan; 51(1):72-9. PubMed ID: 6600411
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance.
    Clayberger C; Wright A; Medeiros LJ; Koller TD; Link MP; Smith SD; Warnke RA; Krensky AM
    Lancet; 1987 Sep; 2(8558):533-6. PubMed ID: 2887833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines.
    Yefenof E; Klein G; Ben-Bassat H; Lundin L
    Exp Cell Res; 1977 Aug; 108(1):185-90. PubMed ID: 196869
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunofluorescence in cells derived from Burkitt's lymphoma.
    Henle G; Henle W
    J Bacteriol; 1966 Mar; 91(3):1248-56. PubMed ID: 4160230
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Concanvalin-A-binding proteins on the surface of human malignant and normal lymphocytes.
    Nilsson SF; Edelson R; Mann D; Green I; Waxdal MJ
    Scand J Immunol; 1979; 9(6):483-92. PubMed ID: 379978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
    Magrath IT; Simon RM
    Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Host defenses in leukemia and Burkitt's tumor.
    Klein G; Klein E; Clifford P
    Cancer; 1968 Apr; 21(4):587-94. PubMed ID: 4296159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.